ES2087850T3 - Proteinas antimicrobianas, composiciones que las contienen y sus aplicaciones. - Google Patents
Proteinas antimicrobianas, composiciones que las contienen y sus aplicaciones.Info
- Publication number
- ES2087850T3 ES2087850T3 ES87117408T ES87117408T ES2087850T3 ES 2087850 T3 ES2087850 T3 ES 2087850T3 ES 87117408 T ES87117408 T ES 87117408T ES 87117408 T ES87117408 T ES 87117408T ES 2087850 T3 ES2087850 T3 ES 2087850T3
- Authority
- ES
- Spain
- Prior art keywords
- daltons
- composition
- matter
- polypeptides
- antimicrobial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
LA PRESENTE INVENCION OFRECE UNA COMPOSICION DE MATERIALES UTIL COMO AGENTE ANTIMICROBIANO. ESTA COMPOSICION DE MATERIALES COMPRENDE AL MENOS DOS POLIPEPTIDOS SELECCIONADOS ENTRE EL GRUPO FORMADO POR POLIPEPTIDOS DE LEUCOCITOS POLIMORFONUCLEARES HUMANOS QUE TIENEN PESOS MOLECULARES APARENTES DE ALREDEDOR DE 3.500 DALTONS, 13.000 DALTONS, 18,000 DALTONS, 29,000 DALTONS Y 54,000 DALTONS. LA COMPOSICION DE MATERIALES TIENE ACTIVIDAD ANTIMICROBIANA INDEPENDIENTE DEL ESFUERZO RESPIRATORIO PARA BACTERIAS Y HONGOS CON PH ENTRE 5 Y 8 APROXIMADAMENTE Y CONCENTRACIONES DE CALCIO HASTA 10 MM APROXIMADAMENTE, ACTIVIDAD ANTIBACTERIANA CON CONCENTRACIONES DE CLORURO SODICO DE HASTA 0,3 M APROXIMADAMENTE, Y ACTIVIDAD FUNGICIDA CON CONCENTRACIONES DE CLORURO SODICO HASTA 0,15 M APROXIMADAMENTE. TAMBIEN SE PRESENTAN METODOS PARA OBTENER ESTA COMPOSICION DE MATERIALES. SE PRESENTAN ADEMAS POLIPEPTIDOS PURIFICADOS UTILES COMO AGENTES ANTIMICROBIANOS Y METODOS PARA OBTENER ESTOS POLIPEPTIDOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93550986A | 1986-11-26 | 1986-11-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2087850T3 true ES2087850T3 (es) | 1996-08-01 |
Family
ID=25467268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87117408T Expired - Lifetime ES2087850T3 (es) | 1986-11-26 | 1987-11-25 | Proteinas antimicrobianas, composiciones que las contienen y sus aplicaciones. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5126257A (es) |
EP (1) | EP0272489B1 (es) |
AT (1) | ATE135229T1 (es) |
AU (1) | AU8189987A (es) |
DE (1) | DE3751741T2 (es) |
DK (1) | DK621787A (es) |
ES (1) | ES2087850T3 (es) |
FI (1) | FI875220A (es) |
GR (1) | GR3019965T3 (es) |
IE (1) | IE873215L (es) |
IL (1) | IL84591A0 (es) |
NO (1) | NO874908L (es) |
PT (1) | PT86220B (es) |
ZA (1) | ZA878880B (es) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0375724B1 (en) * | 1987-08-11 | 1995-05-31 | New York University | Biologically active bactericidal/permeability-increasing protein fragments |
US5198541A (en) * | 1987-08-11 | 1993-03-30 | New York University | Dna encoding bactericidal/permeability-increasing proteins |
US6132775A (en) * | 1987-08-11 | 2000-10-17 | New York University | Therapeutic uses of biologically active bactericidal/permeability-increasing protein fragments |
US6093801A (en) * | 1989-02-14 | 2000-07-25 | Incyte Pharmaceuticals, Inc. | Recombinant analogs of bactericidal/permeability increasing protein |
US5089274A (en) * | 1989-02-14 | 1992-02-18 | Incyte Pharmaceuticals, Inc. | Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders |
US6265187B1 (en) | 1989-02-14 | 2001-07-24 | Incyte Pharmaceuticals, Inc. | Recombinant endotoxin-neutralizing proteins |
US5334584A (en) * | 1989-02-14 | 1994-08-02 | Incyte Pharamaceuticals, Inc. | Recombinant, non-glycosylated bpi protein and uses thereof |
US5171739A (en) * | 1989-02-14 | 1992-12-15 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and preventation thereof using a BPI protein |
US5308834A (en) * | 1989-02-14 | 1994-05-03 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and prevention thereof using a BPI protein |
US5770694A (en) * | 1990-08-13 | 1998-06-23 | Incyte Pharmaceuticals, Inc. | Genetically engineered BPI variant proteins |
US5627262A (en) * | 1989-07-05 | 1997-05-06 | The Board Of Regents Of The University Of Oklahoma | Method and composition for the treatment of septic shock |
US5484885A (en) * | 1989-07-05 | 1996-01-16 | Emory University | Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37 |
US5607916A (en) * | 1989-07-05 | 1997-03-04 | The Board Of Regents Of The University Of Oklahoma | Method and composition for the treatment of septic shock |
US5489676A (en) * | 1990-03-30 | 1996-02-06 | Elsbach; Peter | Polypeptides that potentiate bactericidal/permeability-increasing protein and methods for treating bacterial infections |
US5486503A (en) * | 1991-11-01 | 1996-01-23 | The Trustees Of Boston University | Anti-fungal histatin-based peptides |
US5888477A (en) * | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
US5970973A (en) * | 1993-01-29 | 1999-10-26 | Aradigm Corporation | Method of delivering insulin lispro |
US5915378A (en) * | 1993-01-29 | 1999-06-29 | Aradigm Corporation | Creating an aerosolized formulation of insulin |
US6131567A (en) * | 1993-01-29 | 2000-10-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US6024090A (en) | 1993-01-29 | 2000-02-15 | Aradigm Corporation | Method of treating a diabetic patient by aerosolized administration of insulin lispro |
US5873358A (en) * | 1993-01-29 | 1999-02-23 | Aradigm Corporation | Method of maintaining a diabetic patient's blood glucose level in a desired range |
US5743250A (en) | 1993-01-29 | 1998-04-28 | Aradigm Corporation | Insulin delivery enhanced by coached breathing |
US6653442B1 (en) | 1993-07-20 | 2003-11-25 | Intrabiotics Pharmaceuticals, Inc. | Protegrins |
US5804558A (en) * | 1993-07-20 | 1998-09-08 | University Of California | Protegrins |
US6159936A (en) * | 1993-07-20 | 2000-12-12 | The Regents Of The University Of California | Compositions and methods for treating and preventing microbial and viral infections |
DE69526216T2 (de) * | 1994-01-14 | 2002-11-14 | Xoma Technology Ltd., Berkeley | Antifungaleverfahren und mitteln |
US6025326A (en) * | 1995-07-07 | 2000-02-15 | Intrabiotics Pharmaceuticals, Inc. | Compositions and methods for the prevention and treatment of oral mucositis |
US5994306A (en) * | 1995-11-22 | 1999-11-30 | Intrabiotics Pharmaceuticals, Inc. | Fine-tuned protegrins |
US5916872A (en) * | 1996-07-24 | 1999-06-29 | Intrabiotics Pharmaceuticals, Inc. | Cyclic peptides having broad spectrum antimicrobial activity |
US6174664B1 (en) | 1997-02-05 | 2001-01-16 | University Of Pittsburgh | Screening method for inflammatory diseases using neutrophil defensins and lactoferrin |
US5972594A (en) * | 1997-02-05 | 1999-10-26 | University Of Pittsburgh | Method for screening for reproductive tract inflammation and preeclampsia using neutrophil defensins |
US6531573B1 (en) | 1997-12-18 | 2003-03-11 | Trustees Of Boston University | Antifungal and antibacterial peptides |
CA2296022A1 (en) * | 1998-02-06 | 1999-08-26 | University Of Pittsburgh | Screening method for reproductive tract inflammation and preeclampsia using neutrophil defensins |
US6107460A (en) * | 1999-03-01 | 2000-08-22 | The Board Of Regents Of The University Of Oklahoma | Antimicrobial peptides and methods of use thereof |
US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
SG11202010686SA (en) | 2018-05-23 | 2020-12-30 | Panasonic Ip Man Co Ltd | Tomato pathogenic fungus detecting apparatus and detecting method using same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4343798A (en) * | 1981-06-23 | 1982-08-10 | The Procter & Gamble Company | Topical antimicrobial anti-inflammatory compositions |
-
1987
- 1987-10-06 US US07/106,524 patent/US5126257A/en not_active Expired - Fee Related
- 1987-11-25 EP EP87117408A patent/EP0272489B1/en not_active Expired - Lifetime
- 1987-11-25 IL IL84591A patent/IL84591A0/xx unknown
- 1987-11-25 AT AT87117408T patent/ATE135229T1/de not_active IP Right Cessation
- 1987-11-25 ES ES87117408T patent/ES2087850T3/es not_active Expired - Lifetime
- 1987-11-25 DE DE3751741T patent/DE3751741T2/de not_active Expired - Fee Related
- 1987-11-25 NO NO874908A patent/NO874908L/no unknown
- 1987-11-26 AU AU81899/87A patent/AU8189987A/en not_active Abandoned
- 1987-11-26 ZA ZA878880A patent/ZA878880B/xx unknown
- 1987-11-26 IE IE873215A patent/IE873215L/xx unknown
- 1987-11-26 PT PT86220A patent/PT86220B/pt not_active IP Right Cessation
- 1987-11-26 DK DK621787A patent/DK621787A/da not_active Application Discontinuation
- 1987-11-26 FI FI875220A patent/FI875220A/fi not_active IP Right Cessation
-
1996
- 1996-05-20 GR GR960401339T patent/GR3019965T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE135229T1 (de) | 1996-03-15 |
DE3751741T2 (de) | 1996-11-14 |
EP0272489A2 (en) | 1988-06-29 |
IE873215L (en) | 1988-05-26 |
FI875220A0 (fi) | 1987-11-26 |
DK621787A (da) | 1988-05-27 |
ZA878880B (en) | 1988-05-24 |
AU8189987A (en) | 1988-06-16 |
EP0272489B1 (en) | 1996-03-13 |
US5126257A (en) | 1992-06-30 |
NO874908L (no) | 1988-05-27 |
NO874908D0 (no) | 1987-11-25 |
DE3751741D1 (de) | 1996-04-18 |
GR3019965T3 (en) | 1996-08-31 |
PT86220A (en) | 1987-12-01 |
FI875220A (fi) | 1988-05-27 |
EP0272489A3 (en) | 1990-01-24 |
PT86220B (pt) | 1990-11-07 |
IL84591A0 (en) | 1988-04-29 |
DK621787D0 (da) | 1987-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2087850T3 (es) | Proteinas antimicrobianas, composiciones que las contienen y sus aplicaciones. | |
DK0553307T3 (da) | Herbicide substituerede arylhalogenalkylpyrazoler | |
ES2177555T3 (es) | Octaciclodepsipeptidos con actividad endoparasiticida. | |
ES2040208T3 (es) | Pirazolinas insecticidas. | |
GB9715894D0 (en) | Heterocyclic derivatives | |
ZA839693B (en) | Substituted 4-aminomethylene-chromans and-chromens,processes for their preparation and their use in medicaments | |
ATE157879T1 (de) | Transformierte erythrozyten, verfahren zu deren herstellung, und ihre verwendung in pharmazeutischen zusammensetzungen | |
ES2106042T3 (es) | Inhibidores de la incorporacion de calcio. | |
ZA883444B (es) | ||
ATE40369T1 (de) | Purinderivate. | |
PH27384A (en) | Hair treatment compositions | |
ES2082074T3 (es) | 1,3-difenil-2-propin-1-onas. | |
ATE70444T1 (de) | Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen. | |
ES2006521A6 (es) | Composicion de control de plagas procedimiento derivados benzopiranicos y benzotiopiranicos y metodo de preparar dicha composicion | |
EP0551844A3 (es) | ||
SE8702422D0 (sv) | Improvements in or relating to fungicides | |
ES2079539T3 (es) | Inhibidores de la captacion de calcio. | |
ES2053808T3 (es) | Nuevos compuestos azolicos. | |
ES8507466A1 (es) | Metodo de preparacion de nuevos 1-cicloalquilamino 3-tercbutilamino 2-propanoles | |
DE59308331D1 (de) | Verfahren zur Herstellung von 1-unsubstituierten 3-Aminopyrrolen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 272489 Country of ref document: ES |